A man waits after receiving a dose of COVISHIELD, a COVID-19 vaccine manufactured by the Serum Institute of India, in an auditorium, which has been converted into a temporary vaccination center, in Ahmedabad, India, February 5, 2021. REUTERS / Amit Dave